Body Fluid Analysis - Plerual Fluid
Lung0 parametersReport in 48HrsAt Home
No Fasting Required
Details
Pleural fluid is the lubricating fluid that lies between the parietal pleura (chest wall) and the visceral pleura (lung surface). A pleural effusion occurs when excess fluid accumulates in this space — often due to infection, malignancy, or systemic illness
₹350₹1,750
80% OFF
FREE:AI Insights
Body Fluid Analysis - Pleural Fluid
- Why is it done?
- Diagnostic evaluation of pleural effusion (abnormal fluid accumulation in the pleural space between the lungs and chest wall)
- Determine the underlying cause of fluid accumulation (exudate vs. transudate classification)
- Identify infectious processes such as bacterial, tuberculosis, or fungal infections
- Detect malignant cells indicating cancer involving the pleura
- Evaluate for autoimmune or rheumatologic conditions
- Assess for hemothorax (blood in pleural space) or chylothorax (lymphatic fluid)
- Performed when patients present with dyspnea, chest pain, or imaging shows pleural effusion
- Normal Range
- Appearance: Clear, pale yellow, or colorless
- Volume: Less than 15 mL total in pleural space (minimal physiologic fluid)
- Cell Count - WBC: Less than 1,000 cells/μL (or 1.0 × 10⁹/L)
- Cell Count - RBC: Less than 5,000 cells/μL (or 5.0 × 10⁹/L)
- Protein: Less than 2.0 g/dL (20 g/L) or less than 50% of serum protein
- Glucose: Greater than 60 mg/dL (60-100 mg/dL expected)
- LDH (Lactate Dehydrogenase): Less than two-thirds of upper limit of serum LDH (typically <150-200 IU/L)
- pH: 7.30-7.40 (similar to blood pH)
- Cytology: Negative for malignant cells; no abnormal findings
- Cultures: Negative for bacteria, acid-fast bacilli, and fungi
- Interpretation Guide - Classification:
- Transudate: Protein <2.5 g/dL, LDH <200 IU/L, pleural/serum protein ratio <0.5, indicates non-inflammatory process
- Exudate: Protein >2.5 g/dL, LDH >200 IU/L, pleural/serum protein ratio >0.5, indicates inflammation or infection
- Interpretation
- Exudate Classification (indicates pathology):
- High protein and LDH with normal glucose - suggests infection, malignancy, or inflammation
- Low glucose (<30 mg/dL) - indicates rheumatoid arthritis, systemic lupus erythematosus, or esophageal rupture
- Low pH (<7.20) - associated with infection, malignancy, rheumatologic disease, or esophageal rupture
- Elevated WBC (>1,000 cells/μL) with lymphocyte predominance - suggests tuberculosis, fungal infection, or lymphoma
- Elevated WBC (>1,000 cells/μL) with neutrophil predominance - indicates bacterial infection, acute pneumonia, or acute pulmonary embolism
- Transudate Classification (indicates systemic process):
- Low protein and LDH - suggests congestive heart failure (most common cause), hepatic cirrhosis, renal failure, or malnutrition
- Appearance Abnormalities:
- Cloudy/turbid appearance - indicates presence of WBCs, bacteria, or malignant cells
- Bloody/hemorrhagic fluid (RBC >100,000 cells/μL) - suggests malignancy, trauma, or pulmonary embolism
- Milky appearance - indicates chylothorax (lymphatic obstruction) or empyema
- Greenish/purulent appearance - indicates empyema (pus in pleural space)
- Positive Cytology:
- Malignant cells detected - indicates pleural involvement by cancer (lung cancer most common, followed by breast, gastric, or lymphoma)
- Positive Cultures:
- Positive bacteria - indicates bacterial infection/empyema requiring antibiotics
- Positive acid-fast bacilli (AFB) - indicates tuberculosis (usually 5-10% culture positive)
- Positive fungi - indicates fungal infection such as Cryptococcus, Histoplasma, or Coccidioides
- Associated Organs
- Primary Organ System:
- Respiratory system - pleural membranes surrounding the lungs
- Lungs - primary site affected in pulmonary effusions
- Conditions Associated with Transudate (Non-inflammatory):
- Congestive heart failure (CHF) - most common cause of pleural effusion
- Hepatic cirrhosis - decreased albumin and portal hypertension
- Chronic kidney disease/nephrotic syndrome - protein loss and fluid retention
- Pulmonary embolism - increased vascular permeability
- Severe malnutrition - hypoproteinemia
- Conditions Associated with Exudate (Inflammatory/Infectious):
- Pneumonia and bacterial empyema - bacterial infection
- Tuberculosis - mycobacterial infection
- Fungal infections (Cryptococcus, Coccidioides, Histoplasma)
- Malignancy (lung cancer, breast cancer, lymphoma, mesothelioma)
- Autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis)
- Pulmonary infarction - secondary to thromboembolism
- Pancreatitis - inflammation extending to pleural space
- Esophageal rupture - digestive contents leaking into pleural space
- Special Pleural Fluid Findings:
- Hemothorax - blood in pleural space (RBC >5,000-100,000 cells/μL) from trauma or malignancy
- Chylothorax - lymphatic fluid (triglycerides >110 mg/dL) from lymphatic obstruction or trauma
- Empyema - pus with positive bacterial cultures requiring drainage
- Potential Complications:
- Untreated pleural infection leading to sepsis and respiratory compromise
- Progressive dyspnea and hypoxemia from large effusions compressing lung tissue
- Fibrothorax and lung restriction if effusion is chronic and untreated
- Follow-up Tests
- If Transudate (Non-inflammatory) Suspected:
- Serum albumin and total protein to evaluate nutritional status
- BNP (B-type Natriuretic Peptide) to confirm heart failure etiology
- Echocardiography to evaluate cardiac function
- Liver function tests and coagulation profile if cirrhosis suspected
- Renal function tests (BUN, creatinine) if kidney disease suspected
- If Exudate (Inflammatory/Infectious) Suspected:
- Repeat pleural fluid cultures if first sample not diagnostic
- ADA (Adenosine Deaminase) testing - if tuberculosis suspected (sensitivity 90-100%)
- PCR (Polymerase Chain Reaction) testing for tuberculosis, fungal, or viral pathogens
- Pleural biopsy if tuberculosis highly suspected but cultures negative
- Blood cultures if bacterial infection suspected
- Sputum culture if concurrent pneumonia present
- If Malignancy Suspected:
- Repeat thoracentesis with cytology if first sample non-diagnostic (sensitivity improves with repeat sampling)
- Flow cytometry for lymphoma detection
- Immunohistochemistry to characterize malignant cells
- CT scan of chest to evaluate underlying malignancy
- Pleural biopsy or imaging-guided biopsy if malignancy suspected
- If Autoimmune/Rheumatologic Disease Suspected:
- Pleural fluid ANA (Antinuclear Antibody) test
- Pleural fluid rheumatoid factor
- Pleural fluid complement (C3, C4) levels
- Serum ESR (Erythrocyte Sedimentation Rate) and CRP (C-Reactive Protein)
- Special Testing Based on Findings:
- Triglyceride and cholesterol levels if chylothorax suspected
- Hematocrit comparison (pleural vs. serum) if hemothorax suspected
- Pleural amylase if esophageal rupture or pancreatitis suspected
- Imaging Follow-up:
- Chest X-ray or CT to monitor effusion size and response to treatment
- Ultrasound-guided thoracentesis if repeat sampling needed
- Monitoring Frequency:
- Acute bacterial infection: Re-evaluate within 24-48 hours of treatment initiation
- Tuberculosis: Assess response after 2-4 weeks of therapy
- Malignancy: Follow-up imaging and staging studies based on cancer type
- Heart failure: Re-evaluate effusion after optimizing diuretic therapy
- Fasting Required?
- Fasting Requirement: No - Fasting is NOT required for pleural fluid analysis
- Patient Preparation:
- No special fasting required - patient can eat and drink normally
- Patient should be seated in upright position for 30 minutes prior to procedure if possible to allow fluid to collect at dependent areas
- Remove any restrictive clothing from the chest area
- Empty bladder and bowel before procedure for comfort
- Pre-procedure Instructions:
- Anticoagulant medications (warfarin, heparin, DOACs) - may need to be held per physician discretion; discuss with ordering provider
- Antiplatelet agents (aspirin, clopidogrel) - typically continued but notify provider if on high-dose therapy
- Inform provider of all current medications, especially immunosuppressants
- Recent antibiotic use should be noted as it may affect culture results
- What to Bring:
- Insurance card and photo identification
- List of current medications and allergies
- Any recent imaging (chest X-ray, CT scan) if available
- Post-procedure Instructions:
- Remain under observation for 1-2 hours after procedure to monitor for complications
- Chest X-ray performed post-procedure to rule out pneumothorax
- May resume normal diet and activities once cleared by healthcare provider
- Report any chest pain, increased dyspnea, fever, or dizziness to healthcare provider immediately
How our test process works!
